alea-institute/kl3m-data-sample-004-shuffled huggingface dataset:
```

[Congressional Record Volume 158, Number 122 (Wednesday, September 12, 2012)]
[Extensions of Remarks]
[Page E1488]
From the Congressional Record Online through the Government Publishing Office [www.gpo.gov]

 HONORING LT COL KRISTINE SWAIN FOR 21 YEARS OF SERVICE TO THE UNITED 
                            STATES AIR FORCE

                                 ______
                                 

                         HON. ROBERT J. WITTMAN

                              of virginia

                    in the house of representatives

                     Wednesday, September 12, 2012

  Mr. WITTMAN. Mr. Speaker, I rise today to recognize Lieutenant 
Colonel Kristine Swain for her 21 years of dedicated service to our 
great country. Lt Col Swain graduated from the United States Air Force 
Academy in 1991, and a year later earned her Master of Arts in Russian 
studies from the University of Kansas. During Lt Col Swain's 21 years 
of exceptional service she has served in South Korea, Saudi Arabia, 
Alaska, England, Kosovo, Italy, and Belgium.
  During Lt Col Swain's three year assignment in Brussels she authored 
position papers for use by both the Secretary of Defense and Secretary 
of State for negotiations dealing with the Russian incursion into 
Georgia. She was awarded her second Defense Meritorious Service Medal 
in part for translating complex and delicate guidance into concrete 
NATO policy and action. Lt Col Swain is currently serving as associate 
professor of history at the Air Force Academy where she has authored a 
new course in Russian history and co-authored an innovative senior 
level course on the Cold War. We are all indebted to the selfless 
service members such as Lt Col Swain and many others who courageously 
defend our great nation.

                          ____________________
```
Document Headings

                    Document headings vary by document type but may contain                    the following:                  
                -                       the agency or agencies that issued and signed a document                    
                -                       the number of the CFR title and the number of each part                      the document amends, proposes to amend, or is directly                      related to                    
                -                       the agency docket number / agency internal file number                    
                -                       the RIN which identifies each regulatory action listed in                      the Unified Agenda of Federal Regulatory and Deregulatory                      Actions                    

                    See the                                          Document Drafting Handbook                                        for more details.                  

###### Department of Health and Human Services

###### National Institutes of Health

Pursuant to section 1009 of the Federal Advisory Committee Act, as amended, notice is hereby given of the following meeting.

The meeting will be closed to the public in accordance with the provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5 U.S.C., as amended. The contract proposals and the discussions could disclose confidential trade secrets or commercial property such as patentable material, and personal information concerning individuals associated with the contract proposals, the disclosure of which would constitute a clearly unwarranted invasion of personal privacy. 

*Name of Committee:*                         National Institute of Allergy and Infectious Diseases Special Emphasis Panel; Innovations in Functional B Cell Epitope Discovery (N01).                    

*Date:*                         January 18-19, 2024.                    

*Time:*                         9:00 a.m. to 6:00 p.m.                    

*Agenda:*                         To review and evaluate contract proposals.                    

*Place:*                         National Institute of Allergy and Infectious Diseases, National Institutes of Health, 5601 Fishers Lane, Room 3F52, Rockville, MD 20892 (Virtual Meeting).                    

*Contact Person:*                         Lindsey M. Pujanandez, Ph.D., Scientific Review Officer, Scientific Review Program, Division of Extramural Activities, National Institute of Allergy and Infectious Diseases, National Institutes of Health, 5601 Fishers Lane, Room 3F52, Rockville, MD 20852, (240) 627-3206,                         *lindsey.pujanandez@nih.gov.*

(Catalogue of Federal Domestic Assistance Program Nos. 93.855, Allergy, Immunology, and Transplantation Research; 93.856, Microbiology and Infectious Diseases Research, National Institutes of Health, HHS)

Dated: December 14, 2023. 

Lauren A. Fleck, 

Program Analyst, Office of Federal Advisory Committee Policy.

[FR Doc. 2023-27893 Filed 12-19-23; 8:45 am]

BILLING CODE 4140-01-P
```

[Congressional Bills 115th Congress]
[From the U.S. Government Publishing Office]
[H.R. 4285 Enrolled Bill (ENR)]

        H.R.4285

                     One Hundred Fifteenth Congress

                                 of the

                        United States of America

                          AT THE SECOND SESSION

         Begun and held at the City of Washington on Wednesday,
           the third day of January, two thousand and eighteen

                                 An Act

 
To designate the facility of the United States Postal Service located at 
   123 Bridgeton Pike in Mullica Hill, New Jersey, as the ``James C. 
                 `Billy' Johnson Post Office Building''.

    Be it enacted by the Senate and House of Representatives of the 
United States of America in Congress assembled,
SECTION 1. JAMES C. ``BILLY'' JOHNSON POST OFFICE BUILDING.
    (a) Designation.--The facility of the United States Postal Service 
located at 123 Bridgeton Pike in Mullica Hill, New Jersey, shall be 
known and designated as the ``James C. `Billy' Johnson Post Office 
Building''.
    (b) References.--Any reference in a law, map, regulation, document, 
paper, or other record of the United States to the facility referred to 
in subsection (a) shall be deemed to be a reference to the ``James C. 
`Billy' Johnson Post Office Building''.

                               Speaker of the House of Representatives.

                            Vice President of the United States and    
                                               President of the Senate.
```
# C_2013156EN.01003102.xml

| 1.6.2013 | EN | Official Journal of the European Union | C 156/31 |
| --- | --- | --- | --- |

1.6.2013

EN

Official Journal of the European Union

C 156/31

---

Judgment of the General Court of 12 April 2013 — OSA v Commission

(Case T-418/08) (1)

1

(Competition - Agreements, decisions and concerted practices - Copyright relating to public performance of musical works via the internet, satellite and cable retransmission - Decision finding an infringement of Article 81 EC - Sharing of the geographic market - Bilateral agreements between national collecting societies - Concerted practices precluding the possibility of granting multi-territory and multi-repertoire licences - Proof - Presumption of innocence)

2013/C 156/54

Language of the case: English

Parties

Parties

Applicant: Ochranný svaz autorský pro práva k dílům hudebním o.s. (OSA) (Prague, Czech Republic) (represented by: M. Favart, lawyer)

Applicant:

Defendant: European Commission (represented by: F. Castillo de la Torre and A. Biolan, acting as Agents)

Defendant:

Interveners in support of the applicant: International Confederation of Societies of Authors and Composers (CISAC) (Neuilly-sur-Seine, France) (represented by J.-F. Bellis and K. Van Hove, lawyers); and European Broadcasting Union (EBU) (Grand-Saconnex, Switzerland) (represented by D. Waelbroeck, lawyer, and D. Slater, Solicitor)

Interveners in support of the applicant:

Re:

Re:

Application for annulment in part of Commission Decision C(2008) 3435 final of 16 July 2008 relating to a proceeding under Article 81 [EC] and Article 53 of the EEA Agreement (Case COMP/C2/38.698 — CISAC).

Operative part of the judgment

Operative part of the judgment

The Court:

| 1. | Annuls Article 3 of Commission Decision C(2008) 3435 final of 16 July 2008 relating to a proceeding under Article 81 [EC] and Article 53 of the EEA Agreement (Case COMP/C2/38.698 — CISAC), in so far as it concerns Ochranný svaz autorský pro práva k dílům hudebním o.s. (OSA); |
| --- | --- |

1.

Annuls Article 3 of Commission Decision C(2008) 3435 final of 16 July 2008 relating to a proceeding under Article 81 [EC] and Article 53 of the EEA Agreement (Case COMP/C2/38.698 — CISAC), in so far as it concerns Ochranný svaz autorský pro práva k dílům hudebním o.s. (OSA);

| 2. | Dismisses the remainder of the action; |
| --- | --- |

2.

Dismisses the remainder of the action;

| 3. | Orders the European Commission to pay the costs. |
| --- | --- |

3.

Orders the European Commission to pay the costs.

---

(1)  OJ C 313, 6.12.2008.

1

---
# C_2008327EN.01003801.xml

| 20.12.2008 | EN | Official Journal of the European Union | C 327/38 |
| --- | --- | --- | --- |

20.12.2008

EN

Official Journal of the European Union

C 327/38

---

Action brought on 13 October 2008 — Winzer Pharma v OHIM — Alcon (OFTAL CUSI)

(Case T-462/08)

(2008/C 327/67)

Language in which the application was lodged: German

Parties

Applicant: Dr. Robert Winzer Pharma GmbH (Berlin, Germany) (represented by: S. Schneller, lawyer)

Applicant:

Defendant: Office for Harmonisation in the Internal Market (Trade Marks and Designs)

Defendant:

Other party to the proceedings before the Board of Appeal of OHIM: Alcon, Inc. (Hünenberg, Switzerland)

Other party to the proceedings before the Board of Appeal of OHIM:

Form of order sought

| — | Annul the decision of the Board of Appeal of OHIM of 17 July 2008 (R 1471/2007-1) and the decision of the Opposition Division of OHIM of 16 July 2007 (B 809 899); |
| --- | --- |

—

Annul the decision of the Board of Appeal of OHIM of 17 July 2008 (R 1471/2007-1) and the decision of the Opposition Division of OHIM of 16 July 2007 (B 809 899);

| — | Reject the Community trade mark application No 003679181 ‘Oftal Cusi’; |
| --- | --- |

—

Reject the Community trade mark application No 003679181 ‘Oftal Cusi’;

| — | Order OHIM to pay all the costs of the proceedings. |
| --- | --- |

—

Order OHIM to pay all the costs of the proceedings.

Pleas in law and main arguments

Applicant for a Community trade mark: Alcon Cusì, S.A (subsequently, Alcon, Inc.)

Applicant for a Community trade mark:

Community trade mark applied for: the word mark ‘OFTAL CUSI’ for goods in Class 5.

Community trade mark applied for:

Proprietor of the mark or sign cited in the opposition proceedings: Winzer Pharma

Proprietor of the mark or sign cited in the opposition proceedings:

Mark or sign cited in opposition:‘Ophtal’ (No 489 948) for goods in Class 5.

Mark or sign cited in opposition:

Decision of the Opposition Division: Rejection of the opposition.

Decision of the Opposition Division:

Decision of the Board of Appeal: Dismissal of the appeal.

Decision of the Board of Appeal:

Pleas in law: Infringement of Article 8(1)(b) of Regulation (EC) No 40/1994 (1) in that on account of their similarity there is a likelihood of confusion between the marks at issue.

Pleas in law:

1

---

(1)  Council Regulation (EC) No 40/1994 of 20 December 1993 on the Community trade mark (OJ 1994 L 11, p. 1).

1

---
I 

115TH CONGRESS 

1ST SESSION H. R. 4529 

To direct the Securities and Exchange Commission to revise Form S–3 

so as to add listing and registration of a class of common equity securities on a national securities exchange as an additional basis for satisfying 

the requirements of General Instruction I.B.1. of such form and to 

remove such listing and registration as a requirement of General Instruction I.B.6. of such form. 

IN THE HOUSE OF REPRESENTATIVES 

DECEMBER 1, 2017 

Mrs. WAGNER introduced the following bill; which was referred to the 

Committee on Financial Services 

A BILL 

To direct the Securities and Exchange Commission to revise 

Form S–3 so as to add listing and registration of a 

class of common equity securities on a national securities 

exchange as an additional basis for satisfying the requirements of General Instruction I.B.1. of such form 

and to remove such listing and registration as a requirement of General Instruction I.B.6. of such form. 

1 Be it enacted by the Senate and House of Representa2 tives of the United States of America in Congress assembled, 


ethrower on DSK3G9T082PROD with BILLS
2 

•HR 4529 IH

1 SECTION 1. SHORT TITLE. 

2 This Act may be cited as the ‘‘Accelerating Access 

3 to Capital Act of 2017’’. 

4 SEC. 2. EXPANDED ELIGIBILITY FOR USE OF FORM S–3. 

5 Not later than 45 days after the date of the enact6 ment of this Act, the Securities and Exchange Commission 

7 shall revise Form S–3— 

8 (1) so as to permit securities to be registered 

9 pursuant to General Instruction I.B.1. of such form 

10 provided that either— 

11 (A) the aggregate market value of the vot12 ing and non-voting common equity held by non13 affiliates of the registrant is $75,000,000 or 

14 more; or 

15 (B) the registrant has at least one class of 

16 common equity securities listed and registered 

17 on a national securities exchange; and 

18 (2) so as to remove the requirement of para19 graph (c) from General Instruction I.B.6. of such 

20 form. 

Æ 


ethrower on DSK3G9T082PROD with BILLS
**Exhibit 31.2**

I, Bruce Wright,certify that:

1.     I havereviewed this annual report on Form 10-K of Ultratech, Inc.;

2.     Based onmy knowledge, this report does not contain any untrue statement of a materialfact or omit to state a material fact necessary to make the statements made, inlight of the circumstances under which such statements were made, notmisleading with respect to the period covered by this report;

3.     Based onmy knowledge, the financial statements, and other financial informationincluded in this report, fairly present in all material respects the financialcondition, results of operations and cash flows of the registrant as of, andfor, the periods presented in this report;

4.     Theregistrant’s other certifying officers and I are responsible for establishingand maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and15d-15(e)) for the registrant and have:

a)     Designedsuch disclosure controls and procedures, or caused such disclosure controls andprocedures to be designed under our supervision, to ensure that materialinformation relating to the registrant, including its consolidatedsubsidiaries, is made known to us by others within those entities, particularlyduring the period in which this report is being prepared; and

b)     Evaluatedthe effectiveness of the registrant’s disclosure controls and procedures andpresented in this report our conclusions about the effectiveness of thedisclosure controls and procedures, as of the end of the period covered by thisreport based on such evaluation; and

c)     Disclosedin this report any change in the registrant’s internal control over financialreporting that occurred during the registrant’s most recent fiscal quarter (theregistrant’s fourth fiscal quarter in the case of an annual report) that hasmaterially affected, or is reasonably likely to materially affect, theregistrant’s internal control over financial reporting; and

5.     Theregistrant’s other certifying officer(s) and I have disclosed, based on ourmost recent evaluation of internal control over financial reporting, to theregistrant’s auditors and the audit committee of registrant’s board ofdirectors (or persons performing the equivalent function):

a)     Allsignificant deficiencies and material weaknesses in the design or operation ofinternal control over financial reporting which are reasonably likely toadversely affect the registrant’s ability to record, process, summarize andreport financial information; and

b)     Any fraud, whether or not material, that involvesmanagement or other employees who have a significant role in the registrant’sinternal control over financial reporting.
| Date: March 11, 2004 | ** **                |
|---------------------------|---------------------------|
|                      | /s/ Bruce Wright          |
|                      | Bruce Wright              |
|                      | *Chief Financial Officer* |

 

----
**Exhibit 10.16****Form of Stock Option Agreement****SHARE OPTION AGREEMENT**To:     On                      youwere granted this option (the “Option”) pursuant tothe IPC Holdings, Ltd. (the “Company”) Stock OptionPlan (the “Plan”) topurchase                       sharesof Voting Common Stock, par value $0.01 per share, of theCompany at an exercise priceof                        pershare, subject to the terms and conditions of the Plan assupplemented by this Option. A copy of the Plan is available atthe Company’s principal executive offices which at the datehereof are located at American International Building, 29Richmond Road, Pembroke HM08, Bermuda (“Principal ExecutiveOffices”).     **1. Vesting; Term.** For purposes of Section 6.3of the Plan, this Option shall vest and become exercisable infour equal annual installments on each of the next fouranniversaries of the date of this grant. For purposes ofSection 6.5 of the Plan, this Option shall expire at theclose of business on .     **2. Non-Transferability of Option.** This Option isnon-transferable as provided in Section 6.6 of the Plan.     **3. Mechanics of Exercise.** This Option may beexercised only by written notice to the Secretary of the Companyat its Principal Executive Offices, or to such other person orat such other address as the Company may provide to you for thispurpose. The notice shall state the election to exercise thisOption and the number of shares in respect of which it is beingexercised at such time and shall be signed by you. In the eventthis Option becomes exercisable by another person or personsupon your death pursuant to the Plan, the notice of exerciseshall be accompanied by appropriate proof of the right toexercise this Option.     **4. Agreement to Furnish Information.** At or prior tothe time of exercise of all or a portion of this Option, youagree to furnish such information as the Committee (as definedin the Plan) may in its discretion deem necessary or advisableto assure compliance by the Company with the provisions of anyapplicable legal requirements.     **5. Governing Law.** This Agreement shall be construedand its provisions enforced and administered in accordance withlaws of Bermuda.       IPC Holdings, Ltd.     Accepted and agreed:     By:        Name:      Title:
<TABLE> <S> <C>

<ARTICLE>           5
<LEGEND>
THIS SCHEDULE CONTAINS SUMMARY FINANCIAL INFORMATION EXTRACTED
FROM THE COMBINED FINANCIAL STATEMENTS AT JUNE 30, 1998 FOR THE
YEAR ENDED JUNE 30, 1998 AND IS QUALIFIED IN ITS ENTIRETY BY
REFERENCE TO SUCH FINANCIAL STATEMENTS.
</LEGEND>
<CIK>               0000909115
<NAME>              ROSEWOOD CARE CENTER OF EAST PEORIA
<MULTIPLIER>        1000
       
<S>                             <C>
<PERIOD-TYPE>                   12-MOS
<FISCAL-YEAR-END>                          JUN-30-1998
<PERIOD-START>                             JUL-01-1997
<PERIOD-END>                               JUN-30-1998
<CASH>                                           2,866
<SECURITIES>                                         0
<RECEIVABLES>                                    4,286
<ALLOWANCES>                                       168
<INVENTORY>                                          0
<CURRENT-ASSETS>                                 7,689
<PP&E>                                          25,264
<DEPRECIATION>                                   8,282
<TOTAL-ASSETS>                                  32,421
<CURRENT-LIABILITIES>                            6,966
<BONDS>                                              0
<COMMON>                                            65
<PREFERRED-MANDATORY>                                0
<PREFERRED>                                          0
<OTHER-SE>                                       1,900
<TOTAL-LIABILITY-AND-EQUITY>                    32,421
<SALES>                                         31,498
<TOTAL-REVENUES>                                32,153
<CGS>                                                0
<TOTAL-COSTS>                                   26,773
<OTHER-EXPENSES>                                     0
<LOSS-PROVISION>                                     0
<INTEREST-EXPENSE>                               1,924
<INCOME-PRETAX>                                  3,456
<INCOME-TAX>                                       265
<INCOME-CONTINUING>                                  0
<DISCONTINUED>                                       0
<EXTRAORDINARY>                                      0
<CHANGES>                                            0
<NET-INCOME>                                     3,191
<EPS-PRIMARY>                                       49
<EPS-DILUTED>                                        0
        

</TABLE>
**Exhibit 32.1**





**CERTIFICATION
      PURSUANT TO**


**18 U.S.C.
      SECTION 1350,**


**AS
      ADOPTED PURSUANT TO**


**SECTION 906
      OF THE SARBANES-OXLEY ACT OF 2002**





In
      connection with the Quarterly Report of ZBB Energy Corporation (the “Company”)
      on Form 10-QSB for the three months ended September 30, 2007 as filed
      with the Securities and Exchange Commission on the date hereof (the
“Report”), I, Robert J. Parry, Principal Executive Officer of the Company,
      certify, pursuant to 18 U.S.C. section 906 of the Sarbanes-Oxley Act
      of 2002, that:





(1) The
      Report fully complies with the requirements of section 13(a) or 15(d) of
      the Securities and Exchange Act of 1934; and





(2) The
      information contained in the Report fairly presents, in all material respects,
      the financial condition and result of operations of the Company.





A
      signed
      original of this written statement required by Section 906 has been
      provided to ZBB Energy Corporation and will be retained by ZBB Energy
      Corporation and furnished to the Securities and Exchange Commission or its
      staff
      upon request.





/s/  Robert
                J. ParryRobert
                J. Parry*(Principal
                Executive Officer)*





November
      14, 2007
```

[Congressional Record Volume 158, Number 118 (Friday, August 3, 2012)]
[Senate]
[Page S6021]
From the Congressional Record Online through the Government Publishing Office [www.gpo.gov]

               ADJOURNMENT UNTIL TUESDAY, AUGUST 7, 2012

  The ACTING PRESIDENT pro tempore. The Senate stands adjourned until 
Tuesday, August 7, 2012, at 11 a.m.
  Thereupon, the Senate, at 10:15 and 34 seconds a.m., adjourned until 
Tuesday, August 7, 2012, at 11 a.m.
```